Envestnet Asset Management Inc Genmab A/S Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Genmab A/S stock. As of the latest transaction made, Envestnet Asset Management Inc holds 723,781 shares of GMAB stock, worth $14.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
723,781
Previous 1,043,560
30.64%
Holding current value
$14.8 Million
Previous $25.4 Million
40.63%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
61.3MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$306 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$104 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$63.4 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$57.7 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$57.5 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.5B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...